Samsung Research is leveraging everyday digital data to advance the early detection of Alzheimer’s disease, a significant breakthrough highlighted ahead of World Alzheimer’s Day. With a rapidly aging global population, early diagnosis is crucial in managing the progression of dementia, which affects millions worldwide. Alzheimer’s disease, the most prevalent form of dementia, remains incurable, making early detection essential for improving quality of life. Samsung’s innovative approach utilizes smartphones and wearables to track subtle changes in cognitive function through digital biomarkers. These markers analyze app usage, typing speed, and even walking patterns to identify early signs of cognitive decline. Recent studies presented at the IEEE EMBS conference in Denmark underscored the effectiveness of Samsung’s technology. By focusing on nonverbal data such as typing patterns and gait analysis, researchers have demonstrated that these digital biomarkers can rival traditional hospital-based dementia screenings. Samsung Research aims to continuously refine this technology, collaborating with academic and medical institutions to enhance accuracy. As digital biomarker technology progresses, it holds the promise of not only improving personal health but also reducing the strain on healthcare systems globally. Post navigation NVIDIA’s £2B Boost for UK AI Startups NVIDIA’s £2 Billion AI Boost